A novel cell-based assay for inhibitory anti-muscarinic type 3 receptor antibodies in primary Sjögren's syndrome

Journal of Immunological Methods

Volumn 427, Issue , 2015, Pages 117-121

  Bastian, Isabell ^a   Gordon, Tom P ^a   Jackson, Michael W ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Anti M3R antibodies; Autoantibodies; Functional antibodies; Muscarinic receptors; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; LUCIFERASE; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN; RECEPTOR ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; BIOASSAY; BLOOD SAMPLING; CELL ASSAY; CELL CULTURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LUMINESCENCE; PLATE COUNT; PREDICTIVE VALUE; PRIORITY JOURNAL; REPORTER GENE; SCREENING TEST; SERUM; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SYMPTOM; BLOOD; HEK293 CELL LINE; IMMUNOASSAY; IMMUNOLOGY; PROCEDURES; FEMALE; PRIMARY SJOEGREN SYNDROME;

AUTOANTIBODIES; AUTOANTIGENS; HEK293 CELLS; HUMANS; IMMUNOASSAY; RECEPTOR, MUSCARINIC M3; SJOGREN'S SYNDROME; TRANSFECTION;

EID: 84952639054     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2015.11.005     Document Type: Article

References (30)

1. Borda E., Camusso J.J., Perez Leiros C., Bacman S., Hubscher O., Arana R., Sterin-Borda L. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjogren's syndrome. Mol. Cell. Biochem. 1996, 163-164:335-341.
2. Bournia V.K., Vlachoyiannopoulos P.G. Subgroups of Sjogren syndrome patients according to serological profiles. J. Autoimmun. 2012, 39:15-26.
3. Cai F.Z., Lester S., Lu T., Keen H., Boundy K., Proudman S.M., Tonkin A., Rischmueller M. Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Res. Ther. 2008, 10:R31.
4. Cornec D., Devauchelle-Pensec V., Tobon G.J., Pers J.O., Jousse-Joulin S., Saraux A. B cells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment. J. Autoimmun. 2012, 39:161-167.
5. Dawson L.J., Allison H.E., Stanbury J., Fitzgerald D., Smith P.M. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Rheumatology (Oxford) 2004, 43:1488-1495.
6. Dawson L.J., Stanbury J., Venn N., Hasdimir B., Rogers S.N., Smith P.M. Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006, 54:1165-1173.
7. Fauchais A.L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M.O., Hachulla E., Vidal E., Hatron P.Y. Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun. Rev. 2010, 9:595-599.
8. Gao J., Cha S., Jonsson R., Opalko J., Peck A.B. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum. 2004, 50:2615-2621.
9. Griffin J.W., Cornblath D.R., Alexander E., Campbell J., Low P.A., Bird S., Feldman E.L. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann. Neurol. 1990, 27:304-315.
10. He J., Guo J.P., Ding Y., Li Y.N., Pan S.S., Liu Y., Li Z.G. Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome. Rheumatology (Oxford) 2011, 50:879-884.
11. Jackson M.W., Reed J.H., Smith A.J., Gordon T.P. An autoantibody in narcolepsy disrupts colonic migrating motor complexes. J. Neurosci. 2008, 28:13303-13309.
12. Jin M., Hwang S.M., Davies A.J., Shin Y., Bae J.S., Lee J.H., Lee E.B., Song Y.W., Park K. Autoantibodies in primary Sjogren's syndrome patients induce internalization of muscarinic type 3 receptors. Biochim. Biophys. Acta 2012, 1822:161-167.
13. Koo N.Y., Li J., Hwang S.M., Choi S.Y., Lee S.J., Oh S.B., Kim J.S., Lee E.B., Song Y.W., Park K. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients. Rheumatology (Oxford) 2008, 47:828-833.
14. Kyriakidis N.C., Kapsogeorgou E.K., Tzioufas A.G. A Comprehensive Review of Autoantibodies in Primary Sjogren's Syndrome: Clinical Phenotypes and Regulatory Mechanisms. J. Autoimmun. 2013.
15. Mandl T., Hammar O., Theander E., Wollmer P., Ohlsson B. Autonomic nervous dysfunction development in patients with primary Sjogren's syndrome: a follow-up study. Rheumatology (Oxford) 2010, 49:1101-1106.
16. Marczinovits I., Kovacs L., Gyorgy A., Toth G.K., Dorgai L., Molnar J., Pokorny G. A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome. J. Autoimmun. 2005, 24:47-54.
17. Martel C., Gondran G., Launay D., Lalloue F., Palat S., Lambert M., Ly K., Loustaud-Ratti V., Bezanahary H., Hachulla E., Jauberteau M.O., Vidal E., Hatron P.Y., Fauchais A.L. Active immunological profile is associated with systemic Sjogren's syndrome. J. Clin. Immunol. 2011, 31:840-847.
18. Matsui M., Motomura D., Karasawa H., Fujikawa T., Jiang J., Komiya Y., Takahashi S., Taketo M.M. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9579-9584.
19. Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., Ito S., Tsutsumi A., Sumida T. Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome. Ann. Rheum. Dis. 2005, 64:510-511.
20. Papiris S.A., Tsonis I.A., Moutsopoulos H.M. Sjogren's syndrome. Semin. Respir. Crit. Care Med. 2007, 28:459-471.
21. Park K., Haberberger R.V., Gordon T.P., Jackson M.W. Antibodies interfering with the muscarinic 3 receptor pathway in Sjogren's syndrome inhibit gastrointestinal motility and cholinergic neurotransmission. Arthritis Rheum. 2011, 63:1426-1434.
22. Park K., Park S., Jackson M.W. The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility. Mol. Immunol. 2013, 56:583-587.
23. Ramos-Casals M., Solans R., Rosas J., Camps M.T., Gil A., Del Pino-Montes J., Calvo-Alen J., Jimenez-Alonso J., Mico M.L., Beltran J., Belenguer R., Pallares L. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008, 87:210-219.
24. Reina S., Sterin-Borda L., Orman B., Borda E. Autoantibodies against cerebral muscarinic cholinoceptors in Sjogren syndrome: functional and pathological implications. J. Neuroimmunol. 2004, 150:107-115.
25. Scofield R.H., Farris A.D., Horsfall A.C., Harley J.B. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum. 1999, 42:199-209.
26. Steinbuch M., Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch. Biochem. Biophys. 1969, 134:279-284.
27. Tsuboi H., Matsumoto I., Wakamatsu E., Nakamura Y., Iizuka M., Hayashi T., Goto D., Ito S., Sumida T. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome. Clin. Exp. Immunol. 2010, 162:53-61.
28. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., Weisman M.H. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
29. Waterman S.A., Gordon T.P., Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum. 2000, 43:1647-1654.
30. Waterman S.A., Jackson M.W., Gordon T.P. Functional Effects of Autoantibodies. The Autoimmune Diseases. 2006, 217-236. Elsevier, Sydney.